medigraphic.com
ISSN 2448-5640 (Impreso)
Diario Oficial de la Sociedad Mexicana de Cirugía Cardiaca, A.C., y del Colegio Mexicano de Cirugía Cardiovascular y Torácica, A.C.

2020, Número 3

<< Anterior Siguiente >>

Cir Card Mex 2020; 5 (3)


Neurological complications in infective endocarditis. What does the cardiac surgeon need to know?

Rendón-Elías FG, de la Cerda-Belmont GA, Salas-Ríos CM, Hernández-Sánchez M, Gómez-Danés LH

Idioma: Ingles.
Referencias bibliográficas: 62
Paginas: 81-88
Archivo PDF: 183.35 Kb.


RESUMEN

Las complicaciones neurológicas de lal endocarditis infecciosa tienen una incidencia de 10 al 15% de los pacientes que presentan manifestaciones neurológicas. No obstante, la incidencia del fenómeno silemte cerebral es aun mayor ( de hasta un 80%). La indicación quirúrgica debe tomarse desde la perspectiva de un equipo multidisciplinario (Team de Endocarditis) para lograr el mejor resultado posible. Aunque las recomendaciones específicas van acorde a cada paciente, existen principios como guías clínicas que pueden ser utilizados para ayudar en el proceso de toma de decisiones. El propósito de este artículo es revisar la fisiopatología, epidemiología, manifestaciones clínicas, diagnóstico de la complicaiciones neurológicas de la endocarditis infecciosa, así como le proceso de toma de decisiones para aplicar la indicación de cirugía cardiaca.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosisantimicrobial therapy, and management of complications: a scientific statementfor healthcare professionals from American Heart Association. Circulation 2015; 132:1435-86.

  2. Hoen B, Duval X. Infective Endocarditis. N Engl J Med. 2013; 369(8): 785. doi:10.1056/NEJMc1307282.

  3. Hoen B, Duval X. Clinical practice. Infective endocarditis. N Engl J Med.2013;368: 1425-33.

  4. Garcia-Cabrera E, Fernández-Hidalgo N, Almirante B, et al. Neurological complicationsof infective endocarditis: risks factors, outcome, and impact of cardiacsurgery: multicenter observational study. Circulation 2013; 127:2272-84.

  5. Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcomeof infective endocarditis in the 21st century: the International Collaborationon Endocarditis-Prospective Cohort Study. Arch Intern Med 2009; 169:463-73.

  6. Cooper HA, Thompson EC, Laureno R, et al. Subclinical brain embolization in theleft-side infective endocarditis results from the evaluation by MRI of the brainsof patients with left-sided intracardiac solid masses (EMBOLISM) pilot study.Circulation 2009; 120:585-91.

  7. Sonneville R, Mourvillier, Bouadma L, Wolff M. Management of neurologicalcomplications of infective endocarditis in ICU patients. Ann Intensive Care 2011;1:10. doi: 10.1186/2110-5820-1-10.

  8. Derex L, Bonnefoy E, Delahaye F. Impact of stroke on therapeutic decision makingin infective endocarditis. J Neurol 2010; 257:315-21.

  9. Sonneville R, Mirabel M, Hagège D, et al. Neurologic complications and outcomesof infective endocarditis in critically ill patients: the ENDOcardite en REAnimationprospective multicenter study. Crit Care Med 201; 39:1474-81.

  10. Dickerman SA, Abrutyn E, Barsic B, et al. ICE Investigators: The relationshipbetween the initiation of antimicrobial therapy and the incidence of stroke in infectiveendocarditis: an analysis from the ICE Prospective Cohort Study (ICE- PCS).Am Heart J 2007; 15:1086-94.

  11. Anderson DJ, Goldstein LB, Wilkinson WE, et al.: Stroke location, characterization,severity, and outcome in mitral vs aortic valve endocarditis. Neurology 2003,61:1341-6.

  12. Vilacosta I, Graupner C, San Roman JA, et al.: Risk of embolization after institutionof antibiotic therapy for infective endocarditis. J Am Coll Cardiol 2002,39:1489-95.

  13. Heiro M, Nikoskelainen J, Engblom E, et al. Association pour l’ Etude et laPrévention de l’ Endocardite Infectieuse (AEPEI) Study Group: Neurologic manifestationsof infective endocarditis: a 17-year experience in a teaching hospital inFinland. Arch Intern Med 2000; 160:2781-7.

  14. Lefort A, Lortholary O, Casassus P, Selton-Suty C, Guillevin L, Mainardi JL.beta-Hemolytic Streptococci Infective Endocarditis Study Group. Comparisonbetween adult endocarditis due to β-hemolytic streptococci (serogroups A, B, C,and G) and Streptococcus milleri: a multicenter study. Arch Intern Med 2002;162:2450-6.

  15. Pierrotti LC, Baddour LM: Fungal endocarditis, 1995-2000. Chest 2002; 122:302-10.

  16. Ghoreishi M, Foster N, Pasrija C, Dawood MY, Griffith BP, Gammie JS. Earlyoperation in patients with mitral valve infective endocarditis and acute stroke issafe. Ann Thorac Surg 2018; 105:69-75.

  17. Habib G, Lancelotti P, Antunes MJ, et al: Guía ESC 2015 sobre el tratamiento dela endocarditis infecciosa. Rev Esp Cardiol. 2016;69:69.e1-e49.

  18. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC Guideline for themanagement of patients with valvular heart disease: executive summary: a reportof the American College of Cardiology/American Heart Association Task Forceon Practice Guidelines. Circulation 2014; 129:2440-92.

  19. Baddour LM, Wilson WR, Bayer AS, et al., American Heart Association Committeeon Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council onCardiovascular Disease in the Young, Council on Clinical Cardiology, Council onCardiovascular Surgery and Anesthesia, and Stroke Council. Infective endocarditisin adults: diagnosis, antimicrobial therapy, and management of complications.Circulation 2015; 132:1435–86.

  20. Thuny F, Avierinos JF, Tribouilloy C, et al. Impact of cerebrovascular complicationson mortality and neurologic outcome during infective endocarditis: a prospectivemulticenter study. Eur Heart J 2007; 28:1155-61.

  21. Duval X, Lung B, Klein I, et al. Effect of early cerebral magnetic resonance imagingon clinical decision in infective endocarditis: a prospective study. Ann InternMed 2010; 152:497-504.

  22. Klein I, Iung B, Wolff M, et al. Silent T2* cerebral microbleeds: a potential newimaging clue in infective endocarditis. Neurology 2007; 68:2043. doi: 10.1212/01.wnl.0000266965.04112.bc.

  23. Mourvillier B, Trouillet JL, Timsit JF, et al. Infective endocarditis in the intensivecare unit: clinical spectrum and prognostic factors in 228 consecutive patients.Intensive Care Med 2004; 30:2046-52.

  24. Novy E, Sonneville R, Mazighi M, et al. Neurological complications of infectiveendocarditis: new breakthroughs in diagnosis and management. Med Mal Infect2013; 43:443-50.

  25. Salgado AV, Furlan AJ, Keys TF, Nichols TR, Beck GJ. Neurologic complicationsof endocarditis: a 12-year experience. Neurology 1989;39:173-8.

  26. Tornos P, Almirante B, Mirabet S, Permanyer G, Pahissa A, Soler-Soler J. Infectiveendocarditis due to Staphylococcus aureus: deleterious effect of anticoagulanttherapy. Arch Intern Med 1999; 159:473-45.

  27. Karchmer AW, Dismukes WE, Buckley MJ, Austen WG. Late prosthetic valveendocarditis: clinical features influencing therapy. Am J Med 1978;64:199-206.

  28. Leport C, Vilde JL, Bricaire F, et al. Fifty cases of late prosthetic valve endocarditis:improvement in prognosis over a 15-year period. Br Heart J 1987;58:66-71.

  29. Wilson WR, Geraci JE, Danielson GK, et al. Anticoagulant therapy and centralnervous system complications in patients with prosthetic valve endocarditis. Circulation.1978;57: 1004-7.

  30. Okazaki S, Sakaguchi M, Hyun B, et al. Cerebral microbleeds predict impendingintracranial hemorrhage in infective endocarditis. Cerebrovasc Dis 2011;32:483-8.

  31. Hess A, Klein I, Lung B, et al. Brain MRI findings in neurologically asymptomaticpatients with infective endocarditis. Am J Neuroradiol 2013;34:1579-84.

  32. Peters PJ, Harrison T, Lennox JL. A dangerous dilemma: management of infectiousintracranial aneurysms complicating endocarditis. Lancet Infect Dis2006;6:742-8.

  33. Buckmaster MJ, Curci JA, Murray PR, et al. Source of elastin- degrading enzymesin mycotic aortic aneurysms: bacteria or host inflammatory response? CardiovascSurg 1999;7:16-26.

  34. Tilson MD. Pathogenesis of mycotic aneurysms. Cardiovasc Surg 1999;7:1-2.

  35. Villablanca JP, Jahan R, Hooshi P. Detection and characterization of very smallcerebral aneurysms by using 2D and 3D helical CT angiography. AJNR Am JNeuroradiol 2002;23:1187-98.

  36. Chapot R, Houdart E, Saint-Maurice JP, et al. Endovascular treatment of cerebralmycotic aneurysms. Radiology 2002; 222:389-96.

  37. Gross BA, Puri AS. Endovascular treatment of infectious intracranial aneurysms.Neurosurg Rev 2013;36:11-9.

  38. Karth G, Koreny M, Binder T, et al. Complicated infective endocarditis necessitatingICU admission: clinical course and prognosis. Crit Care 2002; 6:149-54.

  39. Ferro JM, Fonseca AC. Infective endocarditis. Handb Clin Neurol 2014;119:75-91.

  40. Arlotti M, Grossi P, Pea F, et al. Consensus document on controversial issues forthe treatment of infections of the central nervous system: bacterial brain abscess.Int J Infect Dis 2010;14(suppl 4):S79-92.

  41. Davierwala PM, Marin-Cuartas M, Misfeld M, Borger MA. The value of an “EndocarditisTeam”. Ann Cardiothorac Surg 2019;8:621-9.

  42. Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the managementof infective endocarditis: The Task Force for the Management of InfectiveEndocarditis of the European Society of Cardiology (ESC). Endorsed by EuropeanAssociation for Cardio-Thoracic Surgery (EACTS), the European Associationof Nuclear 15. Medicine (EANM). Eur Heart J 2015; 36:3075-128.

  43. Hasbun R, Vikram HR, Barakat LA, Buenconsejo J, Quagliarello VJ. Complicatedleft-sided native valve endocarditis in adults: Risk classification for mortality.JAMA 2003, 289:1933-40.

  44. Wang A, Athan E, Pappas PA, et al. International Collaboration on Endocarditis-Prospective Cohort Study Investigator. Contemporary clinical profile and outcomeof prosthetic valve endocarditis. JAMA 2007;297:1354-61.

  45. Eishi K, Kawazoe K, Kuriyama Y, Kitoh Y, Kawashima Y, Omae T. Surgical managementof infective endocarditis associated with cerebral complications. Multicenterretrospective study in Japan. J Thorac Cardiovasc Surg 1995; 110:1745-1755.

  46. Gillinov AM, Shah RV, Curtis WE, et al. Valve replacement in patients with endocarditisand acute neurologic deficit. Ann Thorac Surg 1996; 61:1125-9.

  47. Ruttmann E, Willeit J, Ulmer H, et al. Neurological outcome of septic cardioembolicstroke after infective endocarditis. Stroke 2006; 37:2094-9.

  48. Snygg-Martin U, Gustafsson L, Rosengren L, et al Cerebrovascular complicationsin patients with left-sided infective endocarditis are common: a prospective studyusing magnetic resonance imaging and neurochemical brain damage markers. ClinInfect Dis 2008; 47:23-30.

  49. Piper C, Wiemer M, Schulte HD, Horstkotte D. Stroke is not a contraindication forurgent valve replacement in acute infective endocarditis. J Heart Valve Dis 2001;10:703-11.

  50. Lalani T, Cabell CH, Benjamin DK, et al, International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators: Analysis of the impactof early surgery on in-hospital mortality of native valve endocarditis: Use of propensityscore and instrumental variable methods to adjust for treatment-selectionbias. Circulation 2010;121:1005-13.

  51. Pettersson GB, Hussain ST. Current AATS guidelines on surgical treatment ofinfective endocarditis. Ann Cardiothorac Surg 2019; 8:630-44.

  52. ht tps : / /www.acc.org/ lates t - in-cardiology/ ten-point s - to- remember/2015/10/15/23/30/2015-esc-guidelines-for-the-management-of-infective-endocarditis.Accessed on May 08, 2020.

  53. Kim DH, Kang DH, Lee MZ, et al. Impact of early surgery on embolic events inpatients with infective endocarditis. Circulation 2010;122(11 Suppl):S17-22.

  54. Roder BL, Wandall DA, Espersen F, Frimodt-Moller N, Skinhoj P, Rosdahl VT.Neurologic manifestations in Staphylococcus aureus endocarditis: a review of 260bacteremic cases in nondrug addicts. Am J Med 1997;102:379-86.

  55. Cabell CH, Pond KK, Peterson GE, et al: The risk of stroke and death in patientswith aortic and mitral valve endocarditis. Am Heart J 2001;142:75-80.

  56. Heiro M, Nikoskelainen J, Engblom E, Kotilainen E, Marttila R, Kotilainen P.Neurologic manifestations of infective endocarditis: a 17-year experience in ateaching hospital in Finland. Arch Intern Med; 2000;160:2781-7.

  57. Tornos P, Almirante B, Mirabet S, Pahissa A, Soler-Soler J. Infective endocarditisdue to Staphylococcus aureus: deleterious effect of anticoagulant therapy. ArchIntern Med 1999; 59:473-5.

  58. Corral I, Martin-Davila P, Fortun J, et al: Trends in neurological complications ofendocarditis. J Neurol 2007; 254:1253-9.

  59. Weinstein L. Life-threatening complications of infective endocarditis and theirmanagement. Arch Intern Med 1986; 146:953-7.

  60. López J, Fernández-Hidalgo N, Revilla A, et al. Internal and external validation ofa model to predict adverse outcomes in patients with left-sided infective endocarditis.Heart 2011;97:1138-42.

  61. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practicalscale. Lancet 1974; 2:81-4.

  62. Morris NA, Matiello M, Lyons JL, Samuels NA. Neurological complications ininfective endocarditis: identification, management, and impact on cardiac surgery.The Neurohospitalist 2014; 4:213-22.




2020     |     www.medigraphic.com